CapsoVision (CV) Stock News
$CV · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on CapsoVision (CV) in the past 30 days. BORSA’s news read on CV is bullish at 59/100, −1 over 24 hours, based on 1 company event over the past 30 days. CV last closed at $6.59 on Oct 9, up 6.81% over five sessions and up 1.07% over the past month. CapsoVision’s next earnings report is scheduled for Thursday, Nov 12.
The wire on $CV
newest first · updated · direct subject stories onlyCapsoVision gets FDA clearance for AI-assisted reading tool AI Highlights
CapsoVision (CV) received FDA clearance for AI Highlights, an AI-assisted reading tool for its CapsoCam Plus capsule endoscopy system. The tool marks suspected abnormal lesions to reduce physician review time and integrates with CapsoView and CapsoCloud platforms.
bullish 80 · impact 60